Advanced colorectal cancer remains difficult to treat, with poor survival rates due to the lack of durable and effective therapies. To address this clinical challenge, this project focuses on the "dark genome", a largely unexplored network of non-coding RNAs and microproteins that is increasingly recognised as an important driver of cancer biology.
You will use state-of-the-art sequencing technologies to systematically identify long non-coding RNAs and microproteins expressed in colorectal cancer. Subsequently, you will apply CRISPR/Cas-based functional genetic screens to determine their role in tumour growth and survival.
The project aims to uncover novel molecular vulnerabilities and establish the foundation for innovative therapies that could significantly improve outcomes for patients with advanced colorectal cancer.
Would you like to know more about the different phases within the PhD trajectory? You can read more about this on this page.
As a PhD candidate, you will investigate the functional role of the dark genome in colorectal cancer. This position is ideal for an enthusiastic and dedicated researcher with a strong interest in cancer biology, gene regulation, non-coding RNAs and bioinformatics.
You will combine experimental and computational approaches and work with a broad range of molecular and cellular techniques, including:
You are an ambitious, curious and highly motivated researcher who enjoys working in an international and collaborative environment. In addition, you have:
Watch this video with more information about joining Amsterdam UMC Research BV.
You will join the Laboratory for Experimental Oncology (LEXOR), located within the Research and Diagnostic Center (RDC/Adore) at Amsterdam UMC. Several research groups within LEXOR study gastrointestinal cancers and aim to improve treatment strategies for patients with these malignancies.
The laboratory uses a wide range of advanced techniques and model systems to understand the mechanisms underlying tumour development, progression and therapy resistance. This multidisciplinary environment offers extensive opportunities to develop both experimental and computational skills.
Our research group specifically focuses on identifying functional non-coding RNA regulatory molecules that are essential for cancer cell survival and tumour development. You will work in an international and collaborative team that values scientific curiosity, knowledge sharing and personal development.
Amsterdam UMC Research BV
Amsterdam UMC Research BV supports non-profit scientific research. In doing so, we provide researchers with everything they need to excel. Our principal investigators (PIs) and project leaders offer support in the field of project management, finance and human resources. In medical scientific research projects, legal support is also provided.
Watch the video to find out more.
During the publication period, applications will be handled continuously. If the vacancy is filled, it will be closed prematurely.
The first round of interviews is scheduled for 20th July. We kindly ask you to keep this in mind. In principle, a second round of interviews could take place the following week.
If you have any questions about this position, please feel free to contact Nicolas Leveille, PI, via n.leveille@amsterdamumc.nl.
A reference check, screening and hiring assessment may be part of the procedure. Read here whether that applies to you. If you join us, we ask you for a VOG (Certificate of Good Conduct).
Internal candidates will be given priority over external candidates in case of equal suitability.
Acquisition in response to this vacancy will not be considered.


